Drug Screening Market size to reach USD 22.24 Bn by the end of the forecast period, Emerging Trends and Regional Insights

Drug Screening Market size to reach USD 22.24 Bn by the end of the forecast period, Emerging Trends and Regional Insights
Drug Screening Market
Drug Screening Market size was valued at USD 7.88 Bn. in 2022 and the total Drug Screening revenue is expected to grow at a CAGR of 15.97% from 2023 to 2029, reaching nearly USD 22.24 Bn.

Pune, 17, April, 2023: A global healthcare business-consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the “Drug Screening Market”, which is a combination of primary data and secondary data. According to the report, the market is to grow from USD 7.88 Bn in 2022 to USD 22.24 Bn in 2029 at a CAGR of 15.97 percent.  

Drug Screening Market Report Scope and Research Methodology

The Drug Screening Market research provides a comprehensive market segmentation analysis along with market estimation for the period 2023-2029. The dynamics section in the report provides detailed information on the market drivers, opportunities, restraints, challenges and advantages. The report focuses on the trends and growth prospects of the Drug Screening industry. To understand the impact of the various factors on the Drug Screening Market, Porter’s five forces analysis is provided in the report. These factors include the bargaining power of suppliers, the competitive intensity of competitors, the threat of substitutes, the threat of new entrants and the bargaining power of buyers, which makes the Drug Screening Market report an investor’s guide. SWOT analysis was conducted to provide the strengths and weaknesses of the Drug Screening Market, while PORTER, PESTEL analysis was employed to understand the potential impact of macro-economic and micro-economic factors influencing the market. 

Drug Screening Market Dynamics

Government funding for pharmaceutical development is a major factor driving the growth of the market. During the forecast period, illicit drug consumption and the increasing prevalence of drug addiction is expected to drive the market. Drug screening adoption is also increasing due to the increasing crime rates associated with drug abuse. 

The global Drug Screening Market is expected to be hampered by stringent government regulations. The lack of infrastructure in developing nations is also restraining market growth. 

Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/1352 

Drug Screening Market Regional Insights

The North America region dominated the global market by holding the largest Drug Screening Market share of about 38.8 percent. This growth of the market is due to the increasing ingesting of illegal drugs. 

The Asia Pacific region is expected to grow at a CAGR of 12.5 percent during the forecast period. This growth of the market is attributed to the increasing number of drug addicts and the development of advanced drug and alcohol screening devices. 

Drug Screening Market Segmentation

By Product & Services

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service


By Sample Type

  • Urine Samples
  • Blood Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples


By Drug Type

  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others


By End-User

  • Drug Testing Laboratories
  • Workplaces
  • Hospitals
  • Others


Drug Screening Key Competitors include:

  • LabCorp (US)
  • Quest Diagnostics (US)
  • Abbott Laboratories (US)
  • Thermo Fisher Scientific, Inc. (US)
  • Alfa Scientific Designs, Inc. (US)
  • OraSure Technologies, Inc. (US)
  • MPD Inc. (US)
  • LifeLoc Technologies (US)
  • Premier Biotech, Inc. (US)
  • Omega Laboratories, Inc. (US)
  • Psychemedics (US)
  • Clinical Reference Laboratory (US)
  • American Bio Medica Corporation (US)
  • ACM Global Laboratories (US)
  • Care Health America Corp (US)
  • Sciteck, Inc. (US)
  • Synens (France)
  • Intoximeters (US)
  • AccuSource (US)
  • Cordant Health Solutions (US)
  • Millennium Health (US)
  • Siemens Healthineers (Germany)
  • Drägerwerk (Germany)
  • Synens SAS (France)
  • Roche (Switzerland)
  • Shimadzu (Japan)


Table of Content for Global Drug Screening Market 

  • Global Drug Screening Market: Research Methodology


  • Global Drug Screening Market: Executive Summary
  • Market Overview and Definitions
  • Introduction to Global Market
  • Summary
  • Key Findings
  • Recommendations for Investors
  • Recommendations for Market Leaders 
  • Recommendations for New Market Entry


  • Global Drug Screening Market: Competitive Analysis
  • MMR Competition Matrix
  • Market Structure by region
  • Competitive Benchmarking of Key Players
  • Consolidation in the Market
  • M&A by region
  • Key Developments by Companies
  • Market Drivers
  • Market Restraints
  • Market Opportunities 
  • Market Challenges
  • Market Dynamics
  • PORTERS Five Forces Analysis
  • Regulatory Landscape by region
  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America
  • COVID-19 Impact


  • Global Drug Screening Market Segmentation
  • Global Market, by Product & Services (2021-2029)
  • Global Market, by Sample Type (2021-2029)
  • Global Market, by Drug Type (2021-2029)
  • Global Market, by End-User (2021-2029)


  • Regional Drug Screening Market (2021-2029)
  • Regional Market, by Product & Services (2021-2029)
  • Regional Market, by Sample Type (2021-2029)
  • Regional Market, by Drug Type (2021-2029)
  • Regional Market, by End-User (2021-2029)
  • Regional Market, by Country (2021-2029)


  • Company Profile: Key players
  • Company Overview
  • Financial Overview
  • Global Presence
  • Capacity Portfolio
  • Business Strategy 
  • Recent Developments


Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/1352 

Key questions answered in the Drug Screening Market are:

  • What is Drug Screening?
  • Which Drug Screening Market segment is expected to grow at a high rate during the forecast period?
  • What are the global factors driving the growth of the Drug Screening Market?
  • What are the factors creating various opportunities for the growth of the Drug Screening Market?
  • What are the recent industry trends that can be implemented to generate additional revenue streams for Drug Screening Market? 
  • How is the intervention from regulatory authority is shaping the Drug Screening Market?
  • What growth strategies are the players considering to increase their presence in Drug Screening?
  • Who are the leading companies and what are their portfolios in Drug Screening Market? 
  • What are the major challenges that the Drug Screening Market could face in the future? 
  • Who held the largest Drug Screening market share in 2022? 


Key Offerings:

  • Past Market Size and Competitive Landscape (2018 to 2021)
  • Past Pricing and price curve by region (2018 to 2021)
  • Market Size, Share, Size & Forecast by different segment | 2023−2029
  • Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
  • Market Segmentation – A detailed analysis by Product & Services, Sample Type, Drug Type, End-User and Region 
  • Competitive Landscape – Profiles of selected key players by region in a strategic perspective 
    • Competitive landscape – Market Leaders, Market Followers, Regional player
    • Competitive benchmarking of key players by region
  • PESTLE Analysis 
  • PORTER’s analysis 
  • Value chain and supply chain analysis 
  • Legal Aspects of business by region
  • Lucrative business opportunities with SWOT analysis 
  • Recommendations 


Maximize Market Research is leading Healthcare research firm, has also published the following reports:

Drug and Alcohol Screening Market – The market size is expected to reach USD 19.21 billion by 2029 at a CAGR of 17.2 percent during the forecast period. The market is expected to be driven by the developing medication and liquor consumption. 

Breast Cancer Drug Market – The market size is expected to reach USD 98.04 billion by 2029 at a CAGR of 14.8 percent during the forecast period. The market is expected to be driven by the high prevalence of breast cancer amongst population across the world. 


About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.


Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India


+91 96071 95908, +91 9607365656

Media Contact
Contact Person: Geeta Yevle
Email: Send Email
Phone: +91 9607365656
Address:3rd Floor, Navale IT Park, Phase 2, Pune Banglore Highway, Narhe,
City: Pune
State: Maharashtra
Country: India
Website: https://www.maximizemarketresearch.com/market-report/global-drug-screening-market/1352/